Board of Directors Approved 2022Q2 Financial Statements
· Issued by Dr.wu Skincare Co., Ltd.
Close
Today's Information
Provided by: DR.WU SKINCARE CO., LTD.
SEQ_NO
1
Date of announcement
2022/08/12
Time of announcement
17:29:31
Subject
Board of Directors Approved 2022Q2
Financial Statements
Date of events
2022/08/12
To which item it meets
paragraph 31
Statement
1.Date of the board of directors submitted or approved:2022/08/12
2.Date of the audit committee approved:2022/08/12
3.Start and end dates of financial reports or unaudited financial
information of the reporting period(XXXX/XX/XX~XXXX/XX/XX):
2022/01/01~2022/06/30
4.Operating revenue accumulated from 1/1 to end of the period
(thousand NTD):423,224
5.Gross profit (loss) from operations accumulated from 1/1 to end of
the period (thousand NTD):293,257
6.Net operating income (loss) accumulated from 1/1 to end of the period
(thousand NTD):170,845
7.Profit (loss) before tax accumulated from 1/1 to end of the period
(thousand NTD):209,245
8.Profit (loss) accumulated from 1/1 to end of the period
(thousand NTD):163,452
9.Profit (loss) during the period attributable to owners of parent
accumulated from 1/1 to end of the period (thousand NTD):163,452
10.Basic earnings (loss) per share accumulated from 1/1 to end of
the period (NTD):3.63
11.Total assets end of the period (thousand NTD):1,846,623
12.Total liabilities end of the period
(thousand NTD):305,771
13.Equity attributable to owners of parent end of the
period (thousand NTD):1,540,852
14.Any other matters that need to be specified:NA
